Soluble interleukin 2 receptor IDs sarcoidosis in uveitis

Soluble interleukin 2 receptor IDs sarcoidosis in uveitis

(HealthDay)—Soluble interleukin 2 receptor (sIL-2R) has slightly better diagnostic value than angiotensin-converting enzyme (ACE) for sarcoidosis in patients with uveitis, according to a study published online Nov. 9 in JAMA Ophthalmology.

Fahriye Groen-Hakan, M.D., from Erasmus University in the Netherlands, and colleagues conducted a cross-sectional retrospective study using data from 249 patients with . Measurements of sIL-2R and ACE from serum samples were determined and compared as diagnostic biomarkers of sarcoidosis.

The researchers found that patients with sarcoidosis-associated uveitis had the highest mean serum sIL-2R and ACE levels and that patients with HLA-B27-associated and varicella-zoster-virus-associated uveitis also had elevated serum sIL-2R levels. There was a significant correlation for serum sIL-2R and ACE levels but no correlation between uveitis activity and either sIL-2R or ACE. The highest Youden index was 0.45 for sIL-2R alone, corresponding to an optimal cutoff of 4,000 pg/mL and providing sensitivity and specificity of 81 and 64 percent, respectively, alone, and 92 and 58 percent, respectively, when combined with chest radiography. At a cutoff of 6,000 pg/mL, chest radiography combined with sIL-2R yielded 77 and 73 percent sensitivity and specificity. At the standard cutoff of 68U/L, combined chest radiography and ACE levels resulted in 70 and 79 percent sensitivity and specificity, respectively.

"This cross-sectional study demonstrates that sIL-2R is a useful marker for diagnosing sarcoidosis in with uveitis and has slightly better diagnostic value than ACE," the authors write.

One author disclosed ties to the pharmaceutical industry; the study was partially funded by AbbVie.


Explore further

Abnormal chest radiograph in active uveitis often sarcoidosis

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal information: JAMA Ophthalmology

Copyright © 2017 HealthDay. All rights reserved.

Citation: Soluble interleukin 2 receptor IDs sarcoidosis in uveitis (2017, November 13) retrieved 27 January 2022 from https://medicalxpress.com/news/2017-11-soluble-interleukin-receptor-ids-sarcoidosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors